Clinical Trial Update: Cholesterol and Antioxidant Treatment in Patients With Smith-Lemli-Opitz Syndrome (SLOS) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating cholesterol and antioxidant treatment for Smith-Lemli-Opitz Syndrome is currently recruiting, with related conditions includ…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cone Rod Dystrophy
• Hearing Loss
• Smith-lemli-opitz Syndrome

Snippet

Sponsor: University of Colorado, Denver | Conditions: Smith-Lemli-Opitz Syndrome, Cone-Rod Dystrophy | Phase 2 | Status: RECRUITING